| 76.41 Delayed Data As of Apr 18 |  -0.89 / -1.15%Today’s Change | 64.76 Today|||52-Week Range 86.27 | -0.59% Year-to-Date |
| Previous close | 77.30 |
| Today’s open | 77.25 |
| Day’s range | 75.96 - 77.35 |
| Volume | 5,053,808 |
| Average volume (3 months) | 2,366,827 |
| Market cap | $185.5B |
| Earnings growth (last year) | +65.34% |
| Earnings growth (this year) | +4.66% |
| Earnings growth (next 5 years) | +5.20% |
| Revenue growth (last year) | +5.41% |
| P/E ratio | 14.2 |
| Price/Sales | 3.87 |
| Price/Book | 2.36 |
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | -0.73 | -0.99% |
| PFEPfizer | -0.50 | -1.25% |
| ABTAbbott Laboratories | +1.04 | +1.43% |
| LLYEli Lilly and Co | -1.30 | -1.12% |
| Next reporting date | April 24, 2019 |
| EPS forecast (this quarter) | $1.23 |
| Annual revenue (last year) | $52.0B |
| Annual profit (last year) | $12.6B |
| Net profit margin | 24.30% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer Vasant Narasimhan |
Chief Financial Officer Harry Werner Kirsch |
Corporate headquarters Basel, Basel-stadt (basle Town) |
